STOCK TITAN

Charles River Laboratories International (CRL) Net Income by Year

CRL NYSE

Charles River Laboratories International, Inc. reported a net loss of $144.3M in fiscal year 2025. This represents a decrease of 750.1% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $40.2M in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Charles River Laboratories International, Inc. has filed alongside them.

FY2025 annual
Net Income -$144.3M
YoY -750.1%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 26, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRL Net Income by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income$40.2M-$144.3M-750.1%$22.2M-95.3%$474.6M-2.4%$486.2M+24.4%$391.0M+7.3%$364.3M+44.6%$252.0M+11.3%$226.4M+83.5%$123.4M-20.3%$154.8M+3.7%$149.3M+17.8%$126.7M+23.2%$102.8M+5.7%$97.3M-11.2%$109.6M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

CRL Net Income by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Net Income$333.1M+512.0%-$1.5M-102.8%-$14.8M-158.3%-$276.6Mn/m$54.4M-21.9%$52.3M-44.4%$25.5M-65.1%-$214.5M-214.7%$69.7M-20.3%$94.1M-3.0%$73.0M-29.3%$187.1M-0.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Charles River Laboratories International, Inc. financials

Frequently Asked Questions

Charles River Laboratories International, Inc. reported a net loss of $144.3M in fiscal year 2025.

Charles River Laboratories International, Inc. (CRL) net income fell by 750.1% year over year, from $22.2M to -$144.3M in fiscal year 2025.

Charles River Laboratories International, Inc. (CRL) reported $40.2M in net income over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Charles River Laboratories International, Inc. (CRL) net income went from $109.6M in fiscal year 2011 to -$144.3M in fiscal year 2025.

Charles River Laboratories International, Inc. (CRL) reported $333.1M in net income in Q3 2026. This represents an increase of 512.0% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Charles River Laboratories International, Inc. (CRL) reported on that line in every period on record.